Keya Medical

Keya Medical Group, established in January 2016, is an international artificial intelligence medical technology service group company that focuses on the application of big data and artificial intelligence technologies in the healthcare field. It is committed to fulfilling real clinical needs by applying AI across various clinical scenarios such as early screening, diagnosis, and treatment, achieving full-process coverage for specific diseases.Keya Medical's core product, "DeepVessel FFR," has obtained the first "Class III Artificial Intelligence Medical Device Registration Certificate (NMPA)" in China as well as EU CE certification, making Keya Medical the only AI medical technology service company with both domestic and international certifications.Keya Medical Group currently operates four global centers (Imaging Analysis Center, Biological Experiment Center, Clinical Testing Center, Engineering Research and Development Center) and two specialized laboratories (Immunotherapy Lab and Artificial Intelligence Lab). By integrating multi-omics information including electronic health records, medical imaging, pathology, biochemistry, immunology, and molecular diagnostics, the company ensures the application of AI in multiple clinical scenarios, truly realizing full-process coverage for single-disease AI applications.